PDCD1 and neoplasm: We observed that 2L4-8 or anti-PD-1 alone exhibited comparable tumor suppression, while the combination group showed significantly enhanced anti-tumor activity compared to monotherapies (Fig. 6B, C), underscoring their synergistic potential.